{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T08:53:48Z","timestamp":1709196828822},"reference-count":40,"publisher":"ARAN Ediciones","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutr Hosp"],"published-print":{"date-parts":[[2019]]},"DOI":"10.20960\/nh.02676","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T13:12:15Z","timestamp":1558012335000},"source":"Crossref","is-referenced-by-count":1,"title":["Papel del m\u00fasculo en el paciente cr\u00edtico"],"prefix":"10.20960","author":[{"given":"Juan Carlos","family":"Montejo Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"S\u00e1nchez-Bayton Griffith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Orej\u00f3n Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8588","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders\u2019 conference. Crit Care Med 2012;40:502-9.","DOI":"10.1097\/CCM.0b013e318232da75"},{"key":"ref2","unstructured":"MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus [letter]. Lancet 1977;2(8038):615."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Bolton CF, Laverty DA, Brown JD, et al. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry 1986;49:563-73.","DOI":"10.1136\/jnnp.49.5.563"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Stevens RD, Marshall SA, Cornblath DR, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 2009;37:S299-S308.","DOI":"10.1097\/CCM.0b013e3181b6ef67"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Hawkins RB, Raymond SL, Stortz JA, et al. Chronic Critical Illness and the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome. Front Immunol 2018;9:1511.","DOI":"10.3389\/fimmu.2018.01511"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Batt J, Dos Santos CC, Cameron JI, et al. Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med 2013;187:238-46.","DOI":"10.1164\/rccm.201205-0954SO"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical illness. JAMA 2013;310:1591-600.","DOI":"10.1001\/jama.2013.278481"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Stevens R, Dowdy DW, Michaels RK, et al. Neuromuscular dysfunction acquired in critically illness: a systematic review. Intensive Care Med 2007;33:1876-91.","DOI":"10.1007\/s00134-007-0772-2"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Witt NJ, Zochodne DW, Bolton CF, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991;99:176-84.","DOI":"10.1378\/chest.99.1.176"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-67.","DOI":"10.1056\/NEJMoa011300"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Garnacho-Montero J, Madrazo-Osuna J, Garc\u00eda-Garmendia JL, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001;27:1288-96.","DOI":"10.1007\/s001340101009"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Kress JP, Hall JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med 2014;370:1626-35.","DOI":"10.1056\/NEJMra1209390"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Ali NA, O\u2019Brien Jr JM, Hoffmann SP, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 2008;178:261-8.","DOI":"10.1164\/rccm.200712-1829OC"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Tillquist M, Kutsogiannis DJ, Wischmeyer PE, et al. Bedside ultrasound is a practical and reliable measurement tool for assessing quadriceps muscle layer thickness. JPEN J Parenter Enteral Nutr 2014;38:886-90.","DOI":"10.1177\/0148607113501327"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Mourtzakis M, Prado CM, Lieffers JR, et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008 ;33:997-1006.","DOI":"10.1139\/H08-075"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Shepherd SJ, Newman R, Brett SJ, et al; Enhancing Rehabilitation After Critical Illness Programme Study Investigators. Pharmacological Therapy for the Prevention and Treatment of Weakness After Critical Illness: A Systematic Review. Crit Care Med 2016;44:1198-205.","DOI":"10.1097\/CCM.0000000000001652"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Van den Berghe G, Schoonheydt K, Becx P, et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005;64:1348-53.","DOI":"10.1212\/01.WNL.0000158442.08857.FC"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Biolo G, de Cicco M, Lorenzon S, et al. Treating hyperglycemia improves skeletal muscle protein metabolism in cancer patients after major surgery. Crit Care Med 2008;36:1768-75.","DOI":"10.1097\/CCM.0b013e318174de32"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Hermans G, de Jonghe B, Bruyninckx F, et al. Clinical review: Critical illness polyneuropathy and myopathy. Crit Care 2008;12:238.","DOI":"10.1186\/cc7100"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Ochoa Gautier JB, Martindale RG, Rugeles SJ, et al. How Much and What Type of Protein Should a Critically Ill Patient Receive? Nutr Clin Pract 2017;32(Suppl. 1):6S-14S.","DOI":"10.1177\/0884533617693609"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). J Parenter Enteral Nutr 2016;40:159-211.","DOI":"10.1177\/0148607115621863"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr 2019;38:48-79.","DOI":"10.1016\/j.clnu.2018.08.037"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Doig GS, Simpson F, Sweetman EA, et al. Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a randomized controlled trial. JAMA 2013;309:2130-8.","DOI":"10.1001\/jama.2013.5124"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Ferrie S, Allman-Farinelli M, Daley M, et al. Protein Requirements in the Critically Ill: A Randomized Controlled Trial Using Parenteral Nutrition. J Parenter Enteral Nutr 2016;40:795-805.","DOI":"10.1177\/0148607115618449"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Fetterplace K, Deane AM, Tierney A, et al. Targeted Full Energy and Protein Delivery in Critically Ill Patients: A Pilot Randomized Controlled Trial (FEED Trial). J Parenter Enteral Nutr 2018;42:1252-62.","DOI":"10.1002\/jpen.1166"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Preiser JC. High protein intake during the early phase of critical illness: yes or no? Crit Care 2018;22:261.","DOI":"10.1186\/s13054-018-2196-5"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Di Girolamo FG, Guadagni M, Fiotti N, et al. Contraction and nutrition interaction promotes anabolism in cachectic muscle. Curr Opin Clin Nutr Metab Care 2019;22:60-7.","DOI":"10.1097\/MCO.0000000000000527"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Hammarqvist F, Jacks J, Wernerman J. Effects on skeletal muscle aminoacids and whole-body nitrogen metabolism of total parenteral nutrition following laparoscopic cholecystectomy and given to healthy volunteers. Clin Nutr 1998;17:205-10.","DOI":"10.1016\/S0261-5614(98)80060-5"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Tang JE, Moore DR, Kujbida GW, et al. Ingestion of whey hydrolysate, casein, or soy protein isolate: effects on mixed muscle protein synthesis at rest and following resistance exercise in young men. J Appl Physiol (1985) 2009;107:987-92.","DOI":"10.1152\/japplphysiol.00076.2009"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Marik PE. Feeding critically ill patients the right \u2018whey\u2019: thinking outside of the box. A personal view. Ann Intensive Care 2015;5:11.","DOI":"10.1186\/s13613-015-0051-2"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Landi F, Calvani R, Picca A, et al. Beta-hydroxy-beta-methylbutyrate and sarcopenia: from biological plausibility to clinical evidence. Curr Opin Clin Nutr Metab Care 2019;22:37-43.","DOI":"10.1097\/MCO.0000000000000524"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Deutz NE, Matheson EM, Matarese LE, et al. NOURISH Study Group. Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: a randomized clinical trial. Clin Nutr 2016;35:18-26.","DOI":"10.1016\/j.clnu.2015.12.010"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Kuhls DA, Rathmacher JA, Musngi MD, et al. Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients. J Trauma 2007;62:125-31.","DOI":"10.1097\/TA.0b013e31802dca93"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Wandrag L, Brett SJ, Frost G, et al. Impact of supplementation with aminoacids or their metabolites on muscle wasting in patients with critical illness or other muscle wasting illness: a systematic review. J Hum Nutr Diet 2015;28:313-30.","DOI":"10.1111\/jhn.12238"},{"key":"ref35","unstructured":"Griffiths RD, Palmer TE, Helliwell T, et al. Effect of passive stretching on the wasting of muscle in the critically ill. Nutrition 1995;11:428-32."},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Hickmann CE, Casta\u00f1ares-Zapatero D, Deldicque L, et al. Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial. Crit Care Med 2018;46:1436-43.","DOI":"10.1097\/CCM.0000000000003263"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Tipping CJ, Harrold M, Holland A, et al. The effects of active mobilisation and rehabilitation in ICU on mortality and function: a systematic review. Intensive Care Med 2017;43:171-83.","DOI":"10.1007\/s00134-016-4612-0"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Hodgson CL, Stiller K, Needham DM, et al. Expert consensus and recommendations on safety criteria for active mobilization of mechanically ventilated critically ill adults. Crit Care 2014;18:658.","DOI":"10.1186\/s13054-014-0658-y"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Prado CM, Purcell SA, Alish C, et al. Implications of low muscle mass across the continuum of care: a narrative review. Ann Med 2018;50:675-93.","DOI":"10.1080\/07853890.2018.1511918"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Arabi YM, Casaer MP, Chapman M, et al. The intensive care medicine research agenda in nutrition and metabolism. Intensive Care Med 2017;43:1239-56.","DOI":"10.1007\/s00134-017-4711-6"}],"container-title":["Nutrici\u00f3n Hospitalaria"],"original-title":[],"deposited":{"date-parts":[[2020,12,13]],"date-time":"2020-12-13T03:05:09Z","timestamp":1607828709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nutricionhospitalaria.org\/articles\/02676\/show"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":40,"URL":"https:\/\/doi.org\/10.20960\/nh.02676","relation":{},"ISSN":["1699-5198","0212-1611"],"issn-type":[{"value":"1699-5198","type":"electronic"},{"value":"0212-1611","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}